Jane Street
VERV

Jane Street’s Verve Therapeutics VERV Stock Holding History

Jane Street’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-198,657
Closed -$2.23M – 11853
2025
Q2 		$2.23M Buy
198,657
+97,923
+97% +$558K ﹤0.01% 4246
2025
Q1 		$460K Sell
100,734
-55,494
-36% -$372K ﹤0.01% 7031
2024
Q4 		$881K Sell
156,228
-60,673
-28% -$342K ﹤0.01% 5621
2024
Q3 		$1.05M Sell
216,901
-36,899
-15% -$214K ﹤0.01% 5789
2024
Q2 		$1.24M Buy
253,800
+226,657
+835% +$1.42M ﹤0.01% 5371
2024
Q1 		$360K Sell
27,143
-245,083
-90% -$3.25M ﹤0.01% 7261
2023
Q4 		$3.79M Buy
272,226
+252,441
+1,276% +$3.13M ﹤0.01% 3262
2023
Q3 		$262K Sell
19,785
-65,139
-77% -$1.05M ﹤0.01% 7268
2023
Q2 		$1.59M Sell
84,924
-69,666
-45% -$1.16M ﹤0.01% 4503
2023
Q1 		$2.23M Buy
154,590
+140,774
+1,019% +$2.76M ﹤0.01% 3628
2022
Q4 		$267K Buy
+13,816
New +$366K ﹤0.01% 7215
2022
Q2 		– Sell
-12,333
Closed -$281K – 10979
2022
Q1 		$281K Sell
12,333
-35,804
-74% -$1.02M ﹤0.01% 8506
2021
Q4 		$1.77M Buy
+48,137
New +$2.02M ﹤0.01% 4708
2021
Q3 		– Sell
-9,492
Closed -$572K – 10789
2021
Q2 		$572K Buy
+9,492
New +$394K ﹤0.01% 6991

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jane Street's VERV Position: Q3 2025 in Review

Jane Street sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 198,657 shares — an estimated $2.23M sold.

Jane Street first reported a position in VERV in Q2 2021 and held it in 14 quarters. The position peaked at $3.79M in Q4 2023. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Jane Street reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 198,657 Verve Therapeutics shares in Q3 2025, an estimated $2.23M.
  • Jane Street first reported a position in Verve Therapeutics in Q2 2021 and held it in 14 quarters.
  • Jane Street's Verve Therapeutics position peaked at $3.79M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.